Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$13.98
0.967.41%
At close: Aug 24, 5:00 PM EST
$14.10
1.088.29%
Pre-Market: 6:00 AM EST
Helus Pharma Inc Analyst Ratings
HELPNASDAQ
Consensus Rating1
Buy
Highest Price Target1
$70.00
Lowest Price Target1
$16.00
Consensus Price Target1
$47.50
Helus Pharma Analyst Ratings and Price Targets | NASDAQ:HELP | Benzinga
Helus Pharma Inc has a consensus price target of $47.5 based on the ratings of 4 analysts. The high is $70 issued by HC Wainwright & Co. on July 9, 2026. The low is $16 issued by Wells Fargo on July 27, 2026. The 3 most-recent analyst ratings were released by TD Cowen, Wells Fargo, and HC Wainwright & Co. on August 20, 2026, July 27, 2026, and July 9, 2026, respectively. With an average price target of $49.33 between TD Cowen, Wells Fargo, and HC Wainwright & Co., there's an implied 249.88% upside for Helus Pharma Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
TD Cowen
Wells Fargo
HC Wainwright & Co.
Canaccord Genuity
1calculated from analyst ratings
Analyst Ratings for Helus Pharma
FAQ
What is the target price for Helus Pharma (HELP) stock?
The latest price target for Helus Pharma (NASDAQ:HELP) was reported by TD Cowen on August 20, 2026. The analyst firm set a price target for $62.00 expecting HELP to rise to within 12 months (a possible 339.72% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Helus Pharma (HELP)?
The latest analyst rating for Helus Pharma (NASDAQ:HELP) was provided by TD Cowen, and Helus Pharma maintained their buy rating.
When was the last upgrade for Helus Pharma (HELP)?
There is no last upgrade for Helus Pharma
When was the last downgrade for Helus Pharma (HELP)?
There is no last downgrade for Helus Pharma.
When is the next analyst rating going to be posted or updated for Helus Pharma (HELP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Helus Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Helus Pharma was filed on August 20, 2026 so you should expect the next rating to be made available sometime around August 20, 2027.
Is the Analyst Rating Helus Pharma (HELP) correct?
While ratings are subjective and will change, the latest Helus Pharma (HELP) rating was a maintained with a price target of $8.00 to $62.00. The current price Helus Pharma (HELP) is trading at is $14.10, which is within the analyst’s predicted range.
